Utility of ¹⁸F-fluoroestradiol (¹⁸F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy

Frank I. Lin, E. M. Gonzalez, S. Kummar, K. Do, J. Shih, S. Adler, K. A. Kurdziel, A. Ton, B. Turkbey, P. M. Jacobs, S. Bhattacharyya, A. P. Chen, J. M. Collins, J. H. Doroshow, P. L. Choyke, M. L. Lindenberg

Research output: Contribution to journal › Article › peer-review